This basic research could one day lead to applied science, like cancer treatments that prevent tumors from becoming resistant to chemotherapy.
Most of the DNA that a cell needs to function is found inside the cell’s nucleus, packaged in chromosomes and inherited from both parents. But mitochondria are special; not only do they have their own genome, small circles of DNA (called mitochondrial DNA or mtDNA), are passed only from a mother to her offspring. Many of our cells contain hundreds—or even thousands—of mitochondria so improperly packaged mtDNA are dealth with biologically, by being recycled when that is possible.
That could also shape how they react to an invading virus—by releasing it from mitochondria and launching an immune response that beefs up the cell’s defenses.
Mitochondria (red), cell nuclei (blue) and mtDNA (white dots). Credit: Salk Institute/Waitt Advanced Biophotonics Center
In the new study, scientists focused on a subset of genes known as interferon-stimulated genes, or ISGs, that are typically activated by the presence of viruses. But in this case, the team realized, the genes were a particular subset of ISGs turned on by viruses. And this same subset of ISGs is often found to be activated in cancer cells that have developed resistance to chemotherapy with DNA-damaging agents like doxyrubicin.
To destroy cancer, doxyrubicin targets the nuclear DNA. But the new study found that the drug also causes the damage and release of mtDNA, which in turn activates ISGs. This subset of ISGs, the group discovered, helps protect nuclear DNA from damage—and, thus, causes increased resistance to the chemotherapy drug. When Shadel and his colleagues induced mitochondrial stress in melanoma cancer cells, the cells became more resistant to doxyrubicin when grown in culture dishes and even in mice, as higher levels of the ISGs were protecting the cell’s DNA.
Most of the time it's a good thing that the mtDNA is more prone to damage because it is a warning to protect healthy cells. But in cancer cells, it means that doxyrubicin—by damaging mtDNA first and setting off molecular alarm bells—can be less effective at damaging the nuclear DNA of cancer cells.
- Cellular Sequencing Technology Provides Deeper Look At Mitochondrial Inherited Disease Risk
- GTPBP3 Mutations Cause Mitochondrial Translation Defect- And Diseases
- New Clues On Link Between Helicobacter Pylori And Stomach Cancer
- Molecular ‘Switch’ That Regulates DNA Replication And Transcription Identified
- Three Person IVF Has Risks- And Now Perhaps A Solution